Standout Papers

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard ... 2013 2026 2017 2021 383
  1. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy (2013)
    Allen P. Kaplan, Dennis K. Ledford et al. Journal of Allergy and Clinical Immunology

Immediate Impact

42 standout
Sub-graph 1 of 20

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Therapeutic effect of bosentan on 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse model
2025 Standout
5 intermediate papers

Works of Nikhil Kamath being referenced

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
2013 Standout

Author Peers

Author Last Decade Papers Cites
Nikhil Kamath 44 55 51 370 243 10 523
William Berger 37 156 6 384 235 15 578
John Eckman 35 42 45 202 93 15 463
Abdelkader Rahmaoui 129 29 5 334 189 6 567
Oded Kimhi 6 34 64 361 163 10 503
Francis 38 10 2 474 330 6 582
Joachim Veith 69 62 439 274 6 630
Małgorzata Setkowicz 104 28 14 215 45 14 547
Mark S. Fradin 17 26 5 128 159 10 565
Alice S. Wilkman 450 35 7 157 55 12 612
Jerry W. Goldberg 35 125 59 406 87 14 563

All Works

Loading papers...

Rankless by CCL
2026